Amikacin
Back to searchMolecule Structure
Scientific Name
Amikacin
Description of the Drug
Amikacin is an aminoglycoside used to treat infections caused by more resistant strains of Gram negative bacteria and some Gram positive bacteria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00479
http://www.drugbank.ca/drugs/DB00479
Brand Name(s)
Not Available
Company Owner(s)
Igi Laboratories Inc, Hospira Worldwide, Inc, Fresenius Kabi Usa Llc, Apothecon Inc Div Bristol Myers Squibb, Sagent Pharmaceuticals Inc, Hospira Inc, Insmed Inc, Abbott Laboratories, Teva Pharmaceuticals Usa, Emcure Pharmaceuticals Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2363135 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2985 | |
| PharmGKB | PA164744372 | |
| Human Metabolome Database | HMDB0014622 | |
| DrugBank | DB00479 | |
| PubChem: Thomson Pharma | 14886882 | |
| PubChem | 37768 | |
| Mcule | MCULE-6148260173 | |
| NMRShiftDB | 60058691 | |
| LINCS | LSM-5935 | |
| Nikkaji | J19.345C | |
| PDBe | AKN | |
| BindingDB | 50237603 | |
| EPA CompTox Dashboard | DTXSID3022586 | |
| DrugCentral | 157 | |
| Brenda | 1394 | |
| ChemicalBook | CB8146049 | |
| Guide to Pharmacology | 10894 | |
| rxnorm | AMIKACIN SULFATE | AMIKACIN |
| KEGG Ligand | C06820 | |
| ChEBI | 2637 | |
| ZINC | ZINC000008214483 |
